Dow HDPE DMDA-8904 HEALTH+ is a high-density polyethylene resin supplied under the Dow Health+ healthcare packaging protocol. Its nominal density is 0.953 g/cm³ when measured according to ASTM D792 or ISO 1183-1; its nominal melt mass-flow rate is 0.40 g/10 min at 190°C/2.16 kg per ASTM D1238 or ISO 1133-1. The product is used primarily in extrusion blow-molded bottles and containers for pharmaceutical, diagnostic, and personal-care applications. The Health+ designation identifies a defined packaging, lot traceability, change-notification, and regulatory-support protocol rather than a separate polymerization route. No finished drug-container claim is established by the resin data sheet alone; final packages must be validated under intended use conditions.

Typical unfabricated resin data-sheet values for the base high-density polyethylene include tensile yield stress near 28 MPa by ASTM D638, flexural modulus near 1,400 MPa by ASTM D790, and notched Izod impact strength above 5 kJ/m² by ASTM D256. These values are typical material values and are not release specifications; they shift with cooling rate, specimen thickness, and conditioning.

The grade is processed on accumulator-head or shuttle blow-molding equipment. The feed throat should remain below 60°C to prevent pellet bridging; barrel zones are commonly set between 160°C and 200°C, while head and die zones are set between 180°C and 210°C. Temperatures above 220°C can increase oxidation and contribute to odor and yellowing. Pre-drying is not normally required when pellets are stored in sealed containers below 50% RH; if surface condensation is present, drying for 2 h at 80°C in a desiccant dryer is sufficient.

What distinguishes Health+ documentation from conventional HDPE blow-molding resin?

The base polymer performance does not originate from a fundamentally different polymerization route; differentiation resides in quality and regulatory controls. Each lot is supplied with a certificate of analysis linking density, melt flow rate, and visual specifications to the Health+ lot-number indexing system. Documentation includes statements of compliance to FDA 21 CFR 177.1520 for olefin polymers and to applicable pharmacopoeial chapters such as USP <661.1> and Ph. Eur. 3.1.3 when the finished container is validated. Change-control notification, raw-material traceability, and periodic regulatory review are embedded in the supply package. Compared with industrial HDPE of similar nominal density, this grade reduces the administrative burden of drug-packaging change control but does not eliminate the need for extractables and leachables assessment on the final article.

Extrusion blow-molding trials on shuttle machines with 20:1 to 30:1 single-screw extruders have shown that die swell is controlled by melt temperature and shear history. At die temperatures below 180°C, the parison can exhibit high melt elasticity and uneven thickness; at temperatures above 215°C, parison sag limits the maximum bottle length. Converging die gaps from 1.5 mm to 3.0 mm are typical starting points. Parison programming should be implemented with 10% to 30% radial thickness profiling at the neck and pinch-off zones to compensate for corner thinning. Clamp force requirements on standard reciprocating blow-molding presses are usually below 15 t for bottles under 1 L, but accumulator-head size and air pressure determine actual mold holding. Mold cooling water flow of 4–8 L/min per mold half is a common starting range for single-cavity tooling; mold temperatures below 10°C may increase frozen-in stress, and mold temperatures above 30°C may extend cycle times.

When wall thickness falls below 0.6 mm, parison control and melt temperature limits become process-critical

The transition from cosmetic container thickness to pharmaceutical packaging thin-wall geometry changes the rheological requirements. At wall thickness below 0.6 mm, melt-flow imbalance across the die can create weld-line thinning at the bottle shoulder and base pinch-off. The upper melt temperature should not exceed 210°C to avoid excessive sag; the lower melt temperature should remain above 180°C to reduce sharkskin on the parison surface. Mold temperature should be held between 10°C and 30°C. Lower mold temperatures improve cycle time but can increase frozen-in stress measured by polarized light; this is a limitation for bottles undergoing autoclave sterilization. Published data for this specific configuration are limited beyond general commercial blow-molding practice.

Applications include bottles for oral liquid pharmaceuticals, diagnostic reagents, and dry-powder dosing containers. The resin has been selected where surface smoothness and lot traceability are required. The high-density backbone gives relatively low water vapour transmission compared with medium-density polyethylene; containers exhibit moisture vapour transmission rates that are geometry-dependent. Final barrier claims must be tested on the blown bottle per ASTM D7709 or equivalent. Compatibility of the final container with the drug product should be tested according to USP <661.2> and relevant ICH guidelines.

Batch-to-batch rheological variability in medium-molecular-weight HDPE

Lot-to-lot consistency of this grade is assessed by capillary rheometry in addition to melt flow rate. While ASTM D1238 provides a single-point flow value at low shear, extrusion blow molding operates at higher shear rates and extensionally dominated flows. The material’s molecular-weight distribution influences die swell and parison stability more strongly than the melt-flow-rate number alone. Production-scale batch variations are usually tighter than broad ASTM specification limits, but the Health+ protocol adds lot-specific documentation. If regrind is reintroduced, changes in melt flow rate should be checked each shift, and regrind should be kept below 20 wt% unless otherwise qualified for the specific container and filling line.

Compared with the lower-melt-flow Dow HDPE grades in the Health+ family, this product offers shorter cycle times and lower head pressure for the same output; it may exhibit slightly reduced environmental stress crack resistance under ASTM D1693 condition B. Compared with higher-melt-flow grades, it provides greater melt strength and better parison hang for larger bottles. Within conventional HDPE blow-molding resins, grades with density near 0.960 g/cm³ have higher flexural modulus but lower stress crack resistance; materials with density near 0.945 g/cm³ have lower stiffness but generally better stress crack resistance. Selection of this grade is therefore a balance between processability, stiffness, and chemical compatibility.

Shot-size and intermittent extrusion boundaries

Accumulator-head machines operate with intermittent discharge. The resin must maintain thermal stability during hold time; typical head residence time should be kept below 8 min at 200°C to avoid molecular-weight changes. Maximum shot size is governed by accumulator capacity and die swell. A starting shot volume of 85% of accumulator capacity is often used to reduce hang time and parison sag. Long hold times increase degradation risk, while short hold times may generate charge-to-charge temperature variation. Published data for this specific configuration are limited; machine-specific trials are required.

Field experience on multi-cavity shuttle lines indicates that blow-pin cooling and mold alignment cause more dimensional rejects than resin lot variation. Bent blow pins with runout above 0.2 mm create non-uniform neck wall and intermittent seal leakage. The resin’s viscosity stabilizes after approximately 30 min of steady-state running; start-up parison weight should be checked after 10 cycles and again after 60 cycles to detect thermal drift. These controls are necessary because the Health+ grade is often used for containers that must pass leak testing, seal-integrity testing, and fill-line torque testing.

Compared with conventional general-purpose HDPE of similar density, DMDA-8904 HEALTH+ differs primarily in controlled documentation, raw-material traceability, and change notification. It is not formulated with intentionally added processing aids or slip agents commonly used in non-health-care packaging. Additive restrictions reduce the number of variables in extractables assessments but also limit processing latitude. Mold-release agents should be avoided unless validated. Compared with HDPE grades of density near 0.960 g/cm³, flexural modulus is lower but stress crack resistance is generally higher. Compared with density near 0.945 g/cm³, stiffness is higher but environmental stress crack resistance may be lower.

Storage conditions should be indoors, below 40°C and 60% RH, out of direct sunlight. Prolonged exposure to UV and heat can lower oxidation-induction time and alter processing behavior. Regrind use should be limited to 20 wt% unless specific process validation demonstrates acceptable gel counts and extractables. Mixtures with other resins should be avoided because drug-packaging regulatory status and additive identity must remain known. Avoid combination with aggressive oxidizing agents unless chemical resistance is confirmed on the final container. The operational boundary for this resin is defined by processing temperature, regrind fraction, and storage environment; final container compliance remains dependent on tooling, sterilization, closure design, and drug-contact validation.